Surgery Partners (SGRY) Director Teresa DeLuca Buys 10,000 Shares

What Happened

• Teresa DeLuca, a director of Surgery Partners, reported an acquisition of 10,000 common shares on 2026-08-18. The reported weighted-average price was $14.35 per share, for an aggregate purchase value of approximately $143,500. This was reported on a Form 4 filed 2026-08-19. Purchases like this are direct buys (code P) and are often viewed as a more informative insider action than routine sales.

Key Details

• Transaction date: 2026-08-18; Form 4 filed: 2026-08-19 (timely filing).
• Transaction type: Purchase (code P) — open-market or private purchase per the filing.
• Shares purchased: 10,000 at a weighted-average price of $14.35; total ≈ $143,500.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnote: The price shown is a weighted average. The reporting person can provide a breakdown of the number of shares bought at each separate price upon request (see footnote F1).
• No 10b5-1 plan, option exercise, gift, or tax-withholding noted in the excerpt.

Context

• This was a straight equity purchase (not an option exercise or award). Insider purchases are generally regarded as a potentially positive signal because they represent the insider putting personal capital into the company, but they do not guarantee future stock performance. Retail investors should consider this alongside company fundamentals and other disclosures.